Diurnal rhythm of α2-noradrenergic receptors in the paraventricular nucleus and other brain areas: Relation to circulating corticosterone and feeding behavior

doi:10.1016/0024-3205(86)90073-1

Life Sciences

Volume 38, Issue 5, 3 February 1986, Pages 473-482

https://doi.org/10.1016/0024-3205(86)90073-1 Get rights and content

Abstract

The paraventricular nucleus α₂-noradrenergic system and the glucocorticoid hormone, corticosterone, are known to modulate feeding behavior and exhibit a circadian pattern which may be related to the natural periodicity of feeding in the rat. The results of the present study indicate that the binding of [³H]p-aminoclonidine to α₂-noradrenergic receptors specifically in the paraventricular nucleus varies concomitantly with plasma corticosterone levels, as well as spontaneous feeding. A monophasic peak of paraventricular noradrenergic receptor binding is detected at the onset of the dark period, when corticosterone levels are highest and feeding is initiated. On the other hand, the supraoptic nucleus exhibits the reverse diurnal pattern, i.e., a significant decline of [³H]p-aminoclonidine binding at the onset of the dark period. Other hypothalamic and extra-hypothalamic areas fail to show significant changes in α₂-noradrenergic receptors as a function of the diurnal cycle. This study supports other evidence indicating a close interaction between circulating corticosterone and α₂-noradrenergic receptors in specific hypothalamic areas. It also reveals a potential importance for this interaction in control of the natural feeding rhythm.

References (50)

M. Perlow et al.
Brain Res.
(1978)
M.S. Kafka et al.
Brain Res.
(1981)
A. Wirz-Justice et al.
Brain Res.
(1983)
K. Krauchi et al.
Brain Res.
(1984)
S.F. Leibowitz
Pharmacol. Biochem. Behav.
(1978)
C. Goldman et al.
Europ. J. Pharmacol.
(1985)
S.F. Leibowitz et al.
Physiol. Behav.
(1984)
J. Le Magnen et al.
Physiol. Behav.
(1970)
M. Palkovits
Brain Res.
(1973)
S.F. Leibowitz et al.
Brain Res.
(1982)

M.M. Bradford

Analyt. Biochem.

(1976)

J. Van Der Gugten et al.

Brain Res.

(1977)

H. Maeda et al.

Life Sci.

(1983)

M. Palkovits et al.

J. Brain Res.

(1974)

S.F. Leibowitz et al.

Pharmacol. Biochem. Behav.

(1985)

S.F. Leibowitz et al.

Brain Res. Bull.

(1985)

L.F. Agnati et al.

Neurosci. Lett.

(1985)

M.I. Fekete et al.

Neurosci. Lett.

(1978)

S.F. Leibowitz et al.

Neuropharmacology

(1978)

S.F. Leibowitz et al.

Brain Res.

(1979)

L.E. Sheving et al.

Amer. J. Physiol.

(1968)

J. Manshardt et al.

Nature (Lond.)

(1968)

F. Cattabeni et al.

J. Neurochem.

(1978)

A.L. Cahill et al.

J. Neurochem.

(1981)

M. Jouvnet

Ergeb. Physiol.

(1972)

Cited by (98)

Noradrenergic circuits
2022, Neurocircuitry of Addiction
The norepinephrine/noradrenergic system has been implicated in substance use disorders for decades, but its importance has been somewhat overshadowed by its precursor molecule dopamine. In this chapter we explore norepinephrine and how noradrenergic signaling contributes to various aspects of substance use disorder. We begin by describing the system, anatomy and development of norepinephrine neurons, norepinephrine in physiological behavior, how to monitor/measure norepinephrine, and how noradrenergic circuits have been assayed and manipulated. We then describe what is known about noradrenergic function and involvement in major misused substances: opioids, alcohol, psychostimulants, nicotine, and cannabis. We finish with examining the role of norepinephrine in non-drug related rewards, such as food and psychosocial rewards.
Involvement of hypothalamic neuropeptide Y in pentazocine induced suppression of food intake in rats
2014, Neuropeptides
Citation Excerpt :
Those animals showing stable baseline intake were selected and assigned to different treatment groups (n = 5–8). Rats usually show a peak feeding activity during the dark phase (Kimura et al., 1970), which coincides with changes of receptors and neurotransmitter levels including NPY in circadian periodicity (Jhanwar-Uniyal et al., 1986; McKibbin et al., 1991). Hence, drug treatments were offered at the onset of the dark phase and feeding was monitored periodically.
The potent orexigenic peptide neuropeptide Y (NPY) has been considered as a possible endogenous ligand for a subpopulation of sigma receptors (SigR). However, their mutual interaction with reference to feeding behavior remains poorly understood. In the present study, we explored the possible interaction between sigma1 receptors (Sig1R) agonist, pentazocine, and NPY on food intake in satiated rats. While pentazocine dose-dependently reduced the food intake, NPY significantly increased it at 2, 4 and 6 h post injection time points. In combination studies, pretreatment with NPY (0.1 nmol/rat, intra-PVN) normalized the inhibitory effect of pentazocine (60 μg/rat, intra-PVN) on food intake. Similarly, pre-treatment with pentazocine (30 μg/rat, intra-PVN) significantly antagonized the orexigenic effect of NPY (0.5 and 1.0 nmol/rat, intra-PVN). Moreover, pentazocine treatment decreased NPY immunoreactivity in arcuate (ARC), paraventricular (PVN), dorsomedial (DMH) and ventromedial (VMH) nuclei of hypothalamus. However, no change was observed in lateral hypothalamus (LH). Study implicates the reduced NPY immunoreactivity for the anorectic effect observed following pentazocine injections. Therefore, the concomitant activation of the NPYergic system along with the Sig1R agonist treatment may serve a useful purpose in the management of the unwanted side effects related to energy homeostasis.
G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei - serpentine gateways to neuroendocrine homeostasis
2012, Frontiers in Neuroendocrinology
Citation Excerpt :
In comparison, reports of ontogenetic variations in GPCR expression in the PVN/SON are scarce, with the transcript or protein level, and/or function of a few GPCRs including the angiotensin II AT1a (mRNA present in PVN E19 onwards [241]), neuropeptide Y1 (mRNA present in PVN P2 onwards coincident with a significant increase in NPY-containing fibers innervating the nucleus [106]), and melanocortin MC4 (mRNA present in PVN and SON at E18 and P27, respectively, approximating the appearance of melanocortin binding sites [162,193]) changing developmentally. At least one GPCR in the PVN and SON is also diurnally regulated – α2-adrenoceptor expression in the PVN peaks at the onset of dark (when CORT levels are highest) whereas in the SON the reverse diurnal pattern is observed [144]. There have been many studies using receptor ARG, IHC or ISHH to demonstrate alterations in GPCR expression by pharmacological or physiological manipulations.
G protein-coupled receptors (GPCRs) are the largest family of transmembrane receptors in the mammalian genome. They are activated by a multitude of different ligands that elicit rapid intracellular responses to regulate cell function. Unsurprisingly, a large proportion of therapeutic agents target these receptors. The paraventricular nucleus (PVN) and supraoptic nucleus (SON) of the hypothalamus are important mediators in homeostatic control. Many modulators of PVN/SON activity, including neurotransmitters and hormones act via GPCRs – in fact over 100 non-chemosensory GPCRs have been detected in either the PVN or SON. This review provides a comprehensive summary of the expression of GPCRs within the PVN/SON, including data from recent transcriptomic studies that potentially expand the repertoire of GPCRs that may have functional roles in these hypothalamic nuclei. We also present some aspects of the regulation and known roles of GPCRs in PVN/SON, which are likely complemented by the activity of ‘orphan’ GPCRs.
Nicotine's attenuation of body weight involves the perifornical hypothalamus
2007, Life Sciences
Previously we showed that intermittent administration of nicotine (NIC) in the dark phase decreased food intake and body weight and this could be blocked when the NIC receptor antagonist mecamylamine was infused into the fourth ventricle. Catecholaminergic neurons adjacent to the fourth ventricle contain NIC receptors and directly innervate the perifornical hypothalamus (PFH) which has been shown to be involved in regulation of feeding. This study explored whether NIC regulates feeding behavior by modulating catecholaminergic input to the PFH. Epinephrine and norepinephrine neuronal input was ablated within the PFH by infusion of 6-hydroxydopamine hydrobromide (6-OHDA), while bupropion was infused to protect dopaminergic neurons. After recovery of body weights to pre-surgery levels, food intake, meal size, meal number and body weight were measured after intermittent NIC injections. The results showed the PFH lesioned animals did not exhibit the typical prolonged drop in food intake, meal size and body weight normally associated with NIC administration. High performance liquid chromatography analyses demonstrated that compared to control rats, 6-OHDA administration significantly reduced PFH norepinephrine and epinephrine levels, but not dopamine levels. These results are consistent with NIC reducing food intake in part by acting through catecholaminergic neurons within or extending through the PFH.
The Darwinian concept of stress: Benefits of allostasis and costs of allostatic load and the trade-offs in health and disease
2005, Neuroscience and Biobehavioral Reviews
Why do we get the stress-related diseases we do? Why do some people have flare ups of autoimmune disease, whereas others suffer from melancholic depression during a stressful period in their life? In the present review possible explanations will be given by using different levels of analysis.
First, we explain in evolutionary terms why different organisms adopt different behavioral strategies to cope with stress. It has become clear that natural selection maintains a balance of different traits preserving genes for high aggression (Hawks) and low aggression (Doves) within a population. The existence of these personality types (Hawks–Doves) is widespread in the animal kingdom, not only between males and females but also within the same gender across species.
Second, proximate (causal) explanations are given for the different stress responses and how they work. Hawks and Doves differ in underlying physiology and these differences are associated with their respective behavioral strategies; for example, bold Hawks preferentially adopt the fight–flight response when establishing a new territory or defending an existing territory, while cautious Doves show the freeze–hide response to adapt to threats in their environment. Thus, adaptive processes that actively maintain stability through change (allostasis) depend on the personality type and the associated stress responses.
Third, we describe how the expression of the various stress responses can result in specific benefits to the organism.
Fourth, we discuss how the benefits of allostasis and the costs of adaptation (allostatic load) lead to different trade-offs in health and disease, thereby reinforcing a Darwinian concept of stress. Collectively, this provides some explanation of why individuals may differ in their vulnerability to different stress-related diseases and how this relates to the range of personality types, especially aggressive Hawks and non-aggressive Doves in a population.
A conceptual framework is presented showing that Hawks, due to inefficient management of mediators of allostasis, are more likely to be violent, to develop impulse control disorders, hypertension, cardiac arrhythmias, sudden death, atypical depression, chronic fatigue states and inflammation. In contrast, Doves, due to the greater release of mediators of allostasis (surplus), are more susceptible to anxiety disorders, metabolic syndromes, melancholic depression, psychotic states and infection.
Pavlovian autoshaping procedures increase plasma corticosterone levels in rats
2002, Pharmacology Biochemistry and Behavior
Pavlovian autoshaping conditioned responses (CRs) are complex sequences of conditioned stimulus (CS)-directed skeletal-motor responses that are elicited by CS objects predictive of food unconditioned stimulus (US). Autoshaping CRs are observed under conditions known to be conducive to elevations in plasma corticosterone levels, as, for example, in response to the eating of food as well as in response to signals predictive of food. Two experiments investigated the relationships between Pavlovian autoshaping procedures, the performance of Pavlovian autoshaping CRs, and plasma corticosterone levels in male Long–Evans rats. In Experiment 1, rats in the CS–US paired group (n=30) were given 20 daily sessions of Pavlovian autoshaping training wherein the insertion of a retractable lever CS was followed by the response-independent presentation of the food US. Tail blood samples obtained after the 20th autoshaping session revealed higher plasma corticosterone levels in the CS–US paired group than in the CS–US random control group (n=10). In Experiment 2, rats (n=35) were assessed for basal plasma corticosterone levels 2 weeks prior to autoshaping training. Plasma samples obtained immediately following the first autoshaping session, and prior to the acquisition of lever-press autoshaping CR performance, revealed higher plasma corticosterone levels in the CS–US paired group (n=24) relative to basal levels. This effect was not observed in the CS–US random control group (n=11). Data suggest that corticosterone release is a physiological endocrine Pavlovian CR induced by lever CS–food US pairings during Pavlovian autoshaping procedures, rather than a by-product of autoshaping CR performance. Implications of the link between autoshaping procedures and corticosterone release are discussed.

View all citing articles on Scopus

View full text

Diurnal rhythm of α2-noradrenergic receptors in the paraventricular nucleus and other brain areas: Relation to circulating corticosterone and feeding behavior

Abstract

Brain Res.

Brain Res.

Brain Res.

Brain Res.

Pharmacol. Biochem. Behav.

Europ. J. Pharmacol.

Physiol. Behav.

Physiol. Behav.

Brain Res.

Brain Res.

Analyt. Biochem.

Brain Res.

Life Sci.

J. Brain Res.

Pharmacol. Biochem. Behav.

Brain Res. Bull.

Neurosci. Lett.

Neurosci. Lett.

Neuropharmacology

Brain Res.

Amer. J. Physiol.

Nature (Lond.)

J. Neurochem.

J. Neurochem.

Ergeb. Physiol.

Diurnal rhythm of α₂-noradrenergic receptors in the paraventricular nucleus and other brain areas: Relation to circulating corticosterone and feeding behavior